22.29 | -0.2600 | -1.15% | Vol 10.85M | 1Y Perf -32.46% |
Oct 4th, 2023 16:00 DELAYED |
BID | 22.27 | ASK | 22.35 | ||
Open | 22.64 | Previous Close | 22.55 | ||
Pre-Market | - | After-Market | 22.25 | ||
- - | -0.04 -0.18% |
Target Price | 42.15 | Analyst Rating | Hold 2.89 | |
Potential % | 89.10 | Finscreener Ranking | ★+ 42.86 | |
Insiders Trans % 3/6/12 mo. | -/-/-100 | Value Ranking | ★★+ 48.84 | |
Insiders Value % 3/6/12 mo. | -/-/-100 | Growth Ranking | + 29.88 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/-100 | Income Ranking | ★★★+ 49.13 | |
Price Range Ratio 52W % | 7.88 | Earnings Rating | Sell | |
Market Cap | 19.23B | Earnings Date | 12th Oct 2023 | |
Alpha | -0.02 | Standard Deviation | 0.09 | |
Beta | 0.72 |
Today's Price Range 21.8222.67 | 52W Range 20.5842.29 | 5 Year PE Ratio Range 8.50114.10 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Sell |
Performance | |||
---|---|---|---|
1 Week | 7.28% | ||
1 Month | -3.76% | ||
3 Months | -22.29% | ||
6 Months | -37.10% | ||
1 Year | -32.46% | ||
3 Years | -36.21% | ||
5 Years | -69.25% | ||
10 Years | -59.09% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 5.73 | |||
ROE last 12 Months | -13.25 | |||
ROA (5Y Avg) | 1.56 | |||
ROA last 12 Months | -3.26 | |||
ROC (5Y Avg) | 7.70 | |||
ROC last 12 Months | -4.46 | |||
Return on invested Capital Q | -6.23 | |||
Return on invested Capital Y | -0.55 | |||
Assets Turnover | 1.70 | |||
Receivables Turnover | 27.80 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-10.60 | ||||
1.53 | ||||
0.24 | ||||
9.60 | ||||
-43.40 | ||||
3.81 | ||||
-2.50 | ||||
23.86 | ||||
72.00B | ||||
Forward PE | 5.96 | |||
PEG | -2.12 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.30 | ||||
0.70 | ||||
0.59 | ||||
1.73 | ||||
-10.90 | ||||
Leverage Ratio | 3.70 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
20.90 | ||||
-3.50 | ||||
-2.00 | ||||
3.00 | ||||
-2.24 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
132.18B | ||||
153.26 | ||||
-3.51 | ||||
0.83 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.28 | ||||
1.92 | ||||
2.16 | ||||
4.87 | ||||
Payout ratio | 72.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | 1.06 | 1.00 | -5.66 |
Q02 2023 | 1.10 | 1.16 | 5.45 |
Q01 2023 | 1.15 | 1.16 | 0.87 |
Q04 2022 | 0.78 | 0.80 | 2.56 |
Q03 2022 | 0.95 | 0.96 | 1.05 |
Q02 2022 | 1.39 | 1.59 | 14.39 |
Q01 2022 | 1.35 | 1.68 | 24.44 |
Q04 2021 | 1.03 | 1.17 | 13.59 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
8/2023 QR | 0.69 | -11.54 | Negative |
8/2023 FY | 3.99 | -0.50 | Negative |
11/2023 QR | 0.93 | -8.82 | Negative |
8/2024 FY | 3.73 | -9.69 | Negative |
Next Report Date | 12th Oct 2023 |
Estimated EPS Next Report | 0.69 |
Estimates Count | 9 |
EPS Growth Next 5 Years % | 5.00 |
Volume Overview | |
---|---|
Volume | 10.85M |
Shares Outstanding | 862.80K |
Shares Float | 597.06M |
Trades Count | 68.21K |
Dollar Volume | 240.49M |
Avg. Volume | 12.67M |
Avg. Weekly Volume | 13.63M |
Avg. Monthly Volume | 14.13M |
Avg. Quarterly Volume | 10.25M |
Walgreens Boots Alliance Inc. (NASDAQ: WBA) stock closed at 22.55 per share at the end of the most recent trading day (a 0.58% change compared to the prior day closing price) with a volume of 12.89M shares and market capitalization of 19.23B. Is a component of S&P 500, NASDAQ 100, Dow Jones 30, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 315000 people. Walgreens Boots Alliance Inc. CEO is Rosalind G. Brewer.
The one-year performance of Walgreens Boots Alliance Inc. stock is -32.46%, while year-to-date (YTD) performance is -39.64%. WBA stock has a five-year performance of -69.25%. Its 52-week range is between 20.58 and 42.29, which gives WBA stock a 52-week price range ratio of 7.88%
Walgreens Boots Alliance Inc. currently has a PE ratio of -10.60, a price-to-book (PB) ratio of 1.53, a price-to-sale (PS) ratio of 0.24, a price to cashflow ratio of 9.60, a PEG ratio of -2.12, a ROA of -3.26%, a ROC of -4.46% and a ROE of -13.25%. The company’s profit margin is -2.24%, its EBITDA margin is -2.00%, and its revenue ttm is $132.18 Billion , which makes it $153.26 revenue per share.
Of the last four earnings reports from Walgreens Boots Alliance Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.69 for the next earnings report. Walgreens Boots Alliance Inc.’s next earnings report date is 12th Oct 2023.
The consensus rating of Wall Street analysts for Walgreens Boots Alliance Inc. is Hold (2.89), with a target price of $42.15, which is +89.10% compared to the current price. The earnings rating for Walgreens Boots Alliance Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Walgreens Boots Alliance Inc. has a dividend yield of 5.28% with a dividend per share of $1.92 and a payout ratio of 72.00%.
Walgreens Boots Alliance Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.88, ATR14 : 0.63, CCI20 : 103.39, Chaikin Money Flow : -0.08, MACD : -0.93, Money Flow Index : 57.25, ROC : 0.58, RSI : 45.35, STOCH (14,3) : 93.36, STOCH RSI : 1.00, UO : 61.98, Williams %R : -6.64), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Walgreens Boots Alliance Inc. in the last 12-months were: John Patrick Driscoll (Buy at a value of $146 988), Kevin M. Ban (Option Excercise at a value of $350 714), Kevin M. Ban (Sold 10 303 shares of value $414 108 ), Nancy M. Schlichting (Sold 16 570 shares of value $660 928 ), Rosalind G. Brewer (Buy at a value of $679 010)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Hold | Hold | Hold |
Walgreens Boots Alliance is a leading retail pharmacy chain, with over 21,000 stores in 50 states and 11 countries. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%).
CEO: Rosalind G. Brewer
Telephone: +1 847 315-3700
Address: 108 Wilmot Road, Deerfield 60015, IL, US
Number of employees: 315 000
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.